Curated News
By: NewsRamp Editorial Staff
March 28, 2025
VentiV Scientific Receives FDA Clearance for Innovative Thrombectomy System
TLDR
- Gain FDA clearance for VentiV Mechanical Thrombectomy system, reducing blood clot removal time and improving patient outcomes.
- VentiV Pulse platform instantly adjusts thrombectomy force to reduce clogging and blood loss during catheter-based procedures.
- VentiV Scientific's innovative medical devices aim to enhance patient care, reduce procedural costs, and save lives through advanced thrombectomy technology.
- Electric pump-based thrombectomy systems revolutionize blood clot removal with VentiV Pulse, offering precision control and improved patient safety.
Impact - Why it Matters
This news matters as the FDA clearance of VentiV Scientific's Mechanical Thrombectomy system signifies a significant advancement in vascular treatment, offering a more efficient and effective solution for removing blood clots. The innovative technology has the potential to enhance patient care, reduce procedural costs, and address unmet clinical needs in treating a range of vascular conditions.
Summary
VentiV Scientific has received FDA clearance for its Mechanical Thrombectomy system, including the new VentiV Pulse platform, designed to remove blood clots from the peripheral vasculature. The system aims to improve patient outcomes by reducing pain, suffering, disability, and saving lives associated with various vascular conditions.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, VentiV Scientific Receives FDA Clearance for Innovative Thrombectomy System
